PURE BIOSCIENCE, INC. Revenues in USD from Q4 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Pure Bioscience, Inc. quarterly/annual Revenues history and growth rate from Q4 2010 to Q2 2025.
  • Pure Bioscience, Inc. Revenues for the quarter ending July 31, 2025 was $763K, a 61.7% increase year-over-year.
  • Pure Bioscience, Inc. Revenues for the twelve months ending July 31, 2025 was $2.2M, a 12.4% increase year-over-year.
  • Pure Bioscience, Inc. annual Revenues for 2025 was $2.2M, a 12.4% increase from 2024.
  • Pure Bioscience, Inc. annual Revenues for 2024 was $1.96M, a 4.49% increase from 2023.
  • Pure Bioscience, Inc. annual Revenues for 2023 was $1.87M, a 3.2% increase from 2022.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)

PURE BIOSCIENCE, INC. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $2.2M $763K +$291K +61.7% May 1, 2025 Jul 31, 2025 10-K 2025-10-29
Q1 2025 $1.91M $489K +$49K +11.1% Feb 1, 2025 Apr 30, 2025 10-Q 2025-06-16
Q4 2024 $1.86M $391K +$66K +20.3% Nov 1, 2024 Jan 31, 2025 10-Q 2025-03-17
Q3 2024 $1.79M $555K -$163K -22.7% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q2 2024 $1.96M $472K -$130K -21.6% May 1, 2024 Jul 31, 2024 10-K 2025-10-29
Q1 2024 $2.09M $440K +$34K +8.37% Feb 1, 2024 Apr 30, 2024 10-Q 2025-06-16
Q4 2023 $2.05M $325K -$71K -17.9% Nov 1, 2023 Jan 31, 2024 10-Q 2025-03-17
Q3 2023 $2.12M $718K +$251K +53.7% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q2 2023 $1.87M $602K +$198K +49% May 1, 2023 Jul 31, 2023 10-K 2024-10-29
Q1 2023 $1.67M $406K -$91K -18.3% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $1.76M $396K -$19K -4.58% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $1.78M $467K -$30K -6.04% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-14
Q2 2022 $1.81M $404K -$453K -52.9% May 1, 2022 Jul 31, 2022 10-K 2023-10-30
Q1 2022 $2.27M $497K -$59K -10.6% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $2.33M $415K -$453K -52.2% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 $2.78M $497K -$920K -64.9% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 $3.7M $857K May 1, 2021 Jul 31, 2021 10-K 2022-10-28
Q1 2021 $556K Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $868K Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 $1.42M Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q1 2012 $207K +$79K +61.7% Feb 1, 2012 Apr 30, 2012 10-Q 2012-06-13
Q4 2011 $221K +$153K +225% Nov 1, 2011 Jan 31, 2012 10-Q 2012-03-16
Q1 2011 $128K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-13
Q4 2010 $68K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16

PURE BIOSCIENCE, INC. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $2.2M +$243K +12.4% Aug 1, 2024 Jul 31, 2025 10-K 2025-10-29
2024 $1.96M +$84K +4.49% Aug 1, 2023 Jul 31, 2024 10-K 2025-10-29
2023 $1.87M +$58K +3.2% Aug 1, 2022 Jul 31, 2023 10-K 2024-10-29
2022 $1.81M -$1.89M -51% Aug 1, 2021 Jul 31, 2022 10-K 2023-10-30
2021 $3.7M -$3.22M -46.5% Aug 1, 2020 Jul 31, 2021 10-K 2022-10-28
2020 $6.92M Aug 1, 2019 Jul 31, 2020 10-K 2021-10-28
2012 $812K +$348K +75% Aug 1, 2011 Jul 31, 2012 10-K 2012-10-29
2011 $464K Aug 1, 2010 Jul 31, 2011 10-K 2012-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.